Exactech AI platform surpasses 100,000 joint replacement surgeries worldwide

GAINESVILLE, Fla., Nov. 20, 2023–(BUSINESS WIRE)–Exactech, a developer and manufacturer of innovative implants, instrumentation and smart technologies for joint replacement surgery, today announced that its Active Intelligence® (AI) platform has a total of more than 100,000 exceeded joint replacement surgeries around the world.

“We are proud to reach this incredible milestone of more than 100,000 patients with the support of our surgeon partners worldwide,” said Darin Johnson, CEO of Exactech. “As a leader in orthopedic innovations, Exactech is focused on pushing technological boundaries to deliver a best-in-class platform of enabling technologies and smart solutions. With a commitment to research and transformative technologies, such as a first-to-market surgical guidance system, machine learning-based tools and personalized planning solutions, we are delivering on our vision to unlock data insights through platform-independent, economical innovations that improve clinical outcomes .”

Active Intelligence was launched in 2021 as a dynamic ecosystem of enabling technologies and smart solutions that provides unparalleled support to surgeons in and outside the operating room. With powerful scheduling software, prediction tools, disruptive surgical technologies and engagement capabilities, Exactech AI provides surgeons with data-rich, low-cost solutions that help improve patient outcomes.

Some notable achievements of Exactech AI include:

• Informed by the collective intelligence of thousands of surgeries, powerful tools have enabled more than 2,500 personalized patient predictions by more than 450 surgeons around the world.
• Personalized preoperative planning software, expanded globally this year, allows surgeons to plan the placement of shoulder components and select implants and sizes for the scapula and humerus based on each patient’s specific anatomy.
• At no capital cost, more than 500 GPS stations are used by thousands of surgeons in hospitals and ASC centers around the world, and in nearly half of Exactech shoulder cases.
• Modern alignment philosophies are supported by our ligament-controlled Newton Knee platform, now used in more than half of our guided, personalized knee surgeries.
• A unique clinical exchange app connects all Exactech surgeons worldwide.

For more information, visit www.ExactechAI.com.

ExactechGPS, Equinoxe Planning App and Predict+ are developed by Blue Ortho, a subsidiary of Exactech, and distributed by Exactech, Inc.

About Exactech

Exactech is a global medical device company that develops and markets orthopedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies for hospitals and physicians. Headquartered in Gainesville, Florida, Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Visit www.exac.com for more information and connect with us on LinkedIn, Vumedi, YouTube, Instagram and Tweet. With Exactech by your side you have EXACTLY what you need.

Contacts

Courtney Adkins
Director of Marketing Communications
media@exac.com

Photo: Business Wire